Link Pharma Chem flips to profit as revenue ticks up 8%

Link Pharma Chem is back in the black. It reported a net profit of ₹7.69 lakh for FY26, a sharp reversal from the ₹102.73 lakh loss seen in FY25.

Revenue for the year climbed 7.9% to ₹27.43 crore. Given the firm's miniscule market capitalization of just ₹13 crore, these figures reflect minor operational shifts rather than any tectonic change in the business model. The board used its meeting to handle standard governance chores, including re-appointing auditors and directors. There is absolutely nothing in this disclosure that suggests a departure from the performance trends already visible in prior quarterly filings. The company remains a nano-cap player with limited scale, and this routine annual report provides no new catalysts for investors to consider.